Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma

被引:5
作者
Shi, Yang [1 ,2 ]
Xiang, Zheng [4 ]
Yang, Huiyu [1 ,2 ]
Khan, Suliman [5 ]
Li, Ruizhe [3 ]
Zhou, Siran [1 ,2 ]
Ullah, Saif [1 ,2 ]
Zhang, Jiyu [1 ,2 ]
Liu, Bingrong [1 ,2 ]
机构
[1] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China
[4] Zhengzhou Univ, Henan Univ, Henan Prov Peoples Hosp, Dept Pathol,Peoples Hosp, Zhengzhou 450003, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou 450000, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 11期
基金
中国国家自然科学基金;
关键词
histone deacetylase inhibitors; LMK-235; esophageal squamous cell carcinoma; tensin-3; histone acetylation; SRC FAMILY KINASES; HDAC INHIBITORS; PROTEIN; EPIGENETICS; COMBINATION; EXPRESSION; PACKAGE;
D O I
10.18632/aging.203091
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Histone acetylation which regulates about 2-10% of genes has been demonstrated to be involved in tumorigenesis of esophageal squamous cell carcinoma (ESCC). In this study, we investigated the treatment response of ESCC to selective histone deacetylase inhibitor (HDACi) LMK-235 and potential biomarker predicting the treatment sensitivity. We identified tensin-3 (TNS3) which was highly over-expressed in ESCC as one of the down-regulated genes in response to LMK-235 treatment. TNS3 was found positively correlated with the tumor malignancy and poor prognosis in the patients. Silencing TNS3 significantly inhibited ESCC cell proliferation both in vitro and in vivo, sensitizing the treatment response to LMK-235. Our findings provide an insight into understanding the oncogenic role of TNS3 in ESCC and its clinical application for HDAC targeted therapy of ESCC.
引用
收藏
页码:15336 / 15352
页数:17
相关论文
共 50 条
[41]   Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway [J].
Ma, Shanshan ;
Liu, Tengfei ;
Xu, Ling ;
Wang, Yaping ;
Zhou, Jiankang ;
Huang, Tuanjie ;
Li, Peng ;
Liu, Hongtao ;
Zhang, Yanting ;
Zhou, Xinkui ;
Cui, Yuanbo ;
Zang, Xingxing ;
Wang, Yuming ;
Guan, Fangxia .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) :22400-22410
[42]   Current status of immune checkpoint inhibitor therapy for advanced esophageal squamous cell carcinoma [J].
Enomoto, Naoki ;
Yamada, Kazuhiko ;
Terayama, Masayoshi ;
Kato, Daiki ;
Yagi, Shusuke ;
Wake, Hitomi ;
Takemura, Nobuyuki ;
Kiyomatsu, Tomomichi ;
Kokudo, Norihiro .
GLOBAL HEALTH & MEDICINE, 2021, 3 (06) :378-385
[43]   Usefulness of microRNA-375 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma [J].
Isozaki, Yuka ;
Hoshino, Isamu ;
Akutsu, Yasunori ;
Hanari, Naoyuki ;
Mori, Mikito ;
Nishimori, Takanori ;
Murakami, Kentaro ;
Akanuma, Naoki ;
Takeshita, Nobuyoshi ;
Maruyama, Tetsuro ;
Toyozumi, Takeshi ;
Takahashi, Masahiko ;
Suito, Hiroshi ;
Matsubara, Hisahiro .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) :1059-1066
[44]   Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma [J].
Liu, Yang ;
Yang, Li-Yan ;
Chen, Ding-Xiong ;
Chang, Chen ;
Yuan, Qing ;
Zhang, Yu ;
Cai, Yan ;
Wei, Wen-Qiang ;
Hao, Jia-Jie ;
Wang, Ming-Rong .
TRANSLATIONAL ONCOLOGY, 2024, 42
[45]   Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of Bone [J].
Venneker, Sanne ;
van Eenige, Robin ;
Kruisselbrink, Alwine B. ;
Palubeckaite, Ieva ;
Taliento, Alice E. ;
Briaire-de Bruijn, Inge H. ;
Hogendoorn, Pancras C. W. ;
van de Sande, Michiel A. J. ;
Gelderblom, Hans ;
Mei, Hailiang ;
Bovee, Judith V. M. G. ;
Szuhai, Karoly .
CANCERS, 2022, 14 (19)
[46]   Role and mechanism of DvI3 in the esophageal squamous cell carcinoma [J].
Chen, X-Q ;
Jiang, J. ;
Wang, X-T ;
Zhang, C-L ;
Ji, A-Y ;
Chen, X-J .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) :7716-7725
[47]   Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma [J].
Chen, Lu ;
Shi, Huanying ;
Zhang, Wenxin ;
Zhu, Yongjun ;
Chen, Haifei ;
Wu, Zimei ;
Qi, Huijie ;
Liu, Jiafeng ;
Zhong, Mingkang ;
Shi, Xiaojin ;
Wang, Tianxiao ;
Li, Qunyi .
BIOCHEMICAL PHARMACOLOGY, 2024, 219
[48]   WAVE3 upregulation in esophageal squamous cell carcinoma and its effect on the migration of human esophageal cancer cell linesin vitro [J].
Li, Xuebing ;
Geng, Jie ;
Ren, Zhenzhen ;
Xiong, Chao ;
Li, Yuqing ;
Liu, Hongchun .
MOLECULAR MEDICINE REPORTS, 2020, 22 (01) :465-473
[49]   Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells [J].
Hoshino, Isamu ;
Matsubara, Hisahiro ;
Akutsu, Yasunori ;
Nishimori, Takanori ;
Yoneyama, Yasuo ;
Murakami, Kentaro ;
Komatsu, Aki ;
Sakata, Haruhito ;
Matsushita, Kazuyuki ;
Ochiai, Takenori .
ONCOLOGY REPORTS, 2007, 18 (03) :585-592
[50]   Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkers [J].
Fahan Ma ;
Yan Li ;
Chan Xiang ;
Bing Wang ;
Jie Lv ;
Jinzhi Wei ;
Zhaoyu Qin ;
Yan Pu ;
Kai Li ;
Haohua Teng ;
Subei Tan ;
Jinwen Feng ;
Zhanxian Shang ;
Yunzhi Wang ;
Sha Tian ;
Changsheng Du ;
Yuchen Han ;
Chen Ding .
Journal of Hematology & Oncology, 17